The Benefit of Bermekimab in Patients With Systemic Sclerosis
Clinical trial NCT04045743 · COMPLETED
Trial details
- NCT number
- NCT04045743
- Sponsor
- Hellenic Institute for the Study of Sepsis
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-19
- Primary completion
- 2021-01-07
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.